Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT00147199 · COMPLETED

Trial details

NCT number: NCT00147199
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2005-06-01
Primary completion: 2007-10-01
Enrollment: 235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.